A large-scale retrospective analysis demonstrated that serum CXCL8 levels are associated with increased monocyte and neutrophil infiltration as well as worse prognosis in advanced cancer patients with immune checkpoint inhibitors [193]. This evidence concerns the gene CXCL8 and cancer.